Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.
Ann Intern Med. 2011 Dec 6;155(11):742-50. doi: 10.7326/0003-4819-155-11-201112060-00006.
BACKGROUND: Prior studies have found inverse associations between high-density lipoprotein cholesterol (HDL-C) or apolipoprotein A-I levels and cardiovascular disease (CVD). Whether this observation is consistent across low-density lipoprotein cholesterol (LDL-C) levels or total atherogenic particle burden (apolipoprotein B100) is less well-studied, particularly in women. OBJECTIVE: To determine the association between HDL-C or apolipoprotein A-I level and CVD across a range of LDL-C and apolipoprotein B100 values. DESIGN: Prospective cohort study. SETTING: The Women's Health Study, a cohort of U.S. female health professionals. PARTICIPANTS: 26,861 initially healthy women, aged 45 years or older at study entry (1992-1995), who were followed for a mean of approximately 11 years. MEASUREMENTS: Baseline lipids were measured directly, and apolipoproteins were measured with immunoassays. Outcomes were incident total CVD (n = 929), coronary events (n = 602), and stroke (n = 319). RESULTS: In multivariable analyses, HDL-C and apolipoprotein A-I levels were inversely associated with CVD and coronary events but not stroke. Adjusted coronary hazard ratios for decreasing quintiles of HDL-C were 1.00 (reference), 1.23 (95% CI, 0.85 to 1.78), 1.42 (CI, 0.98 to 2.06), 1.90 (CI, 1.33 to 2.71), and 2.19 (CI, 1.51 to 3.19) (P for linear trend < 0.001); corresponding hazard ratios for apolipoprotein A-I were 1.00 (reference), 0.98 (CI, 0.71 to 1.35), 1.02 (CI, 0.72 to 1.44), 1.37 (CI, 0.98 to 1.90), and 1.58 (CI, 1.14 to 2.20) (P for linear trend = 0.005). Consistent inverse associations were found for HDL-C with coronary events across a range of LDL-C values, including among women with low LDL-C levels. No associations were noted for HDL-C or apolipoprotein A-I among women with low apolipoprotein B100 values (<0.90 g/L). LIMITATION: Participants were at low risk for CVD, the number of events in the lowest apolipoprotein B100 stratum was small, only a single baseline measurement was obtained, and residual confounding may have occurred. CONCLUSION: Consistent inverse associations were found for HDL-C with incident coronary events among women with a range of LDL-C values. Among women with low total atherogenic particle burden (apolipoprotein B100 level <0.90 g/L), few events occurred and no associations were seen. PRIMARY FUNDING SOURCE: Merck & Co. and the National Heart, Lung, and Blood Institute and National Cancer Institute, National Institutes of Health.
背景:先前的研究发现高密度脂蛋白胆固醇(HDL-C)或载脂蛋白 A-I 水平与心血管疾病(CVD)呈负相关。然而,这种观察结果在低密度脂蛋白胆固醇(LDL-C)水平或总致动脉粥样硬化颗粒负担(载脂蛋白 B100)方面的一致性研究较少,尤其是在女性中。
目的:确定 HDL-C 或载脂蛋白 A-I 水平与不同 LDL-C 和载脂蛋白 B100 值范围内 CVD 的相关性。
设计:前瞻性队列研究。
地点:美国女性健康专业人员组成的妇女健康研究队列。
参与者:26861 名最初健康的女性,年龄在 45 岁或以上(1992-1995 年),平均随访约 11 年。
测量:基线脂质直接测量,载脂蛋白通过免疫测定法测量。结果是总 CVD(n=929)、冠心病事件(n=602)和中风(n=319)的发生。
结果:在多变量分析中,HDL-C 和载脂蛋白 A-I 水平与 CVD 和冠心病事件呈负相关,但与中风无关。HDL-C 五分位数降低的校正冠心病风险比为 1.00(参考)、1.23(95%CI,0.85 至 1.78)、1.42(CI,0.98 至 2.06)、1.90(CI,1.33 至 2.71)和 2.19(CI,1.51 至 3.19)(线性趋势 P<0.001);相应的载脂蛋白 A-I 风险比为 1.00(参考)、0.98(CI,0.71 至 1.35)、1.02(CI,0.72 至 1.44)、1.37(CI,0.98 至 1.90)和 1.58(CI,1.14 至 2.20)(线性趋势 P=0.005)。在 LDL-C 值的范围内,包括在 LDL-C 水平较低的女性中,均发现 HDL-C 与冠心病事件呈一致的负相关。在载脂蛋白 B100 值较低(<0.90 g/L)的女性中,未观察到 HDL-C 或载脂蛋白 A-I 的相关性。
局限性:参与者 CVD 风险较低,最低载脂蛋白 B100 分层的事件数量较少,仅获得单次基线测量,可能存在残余混杂。
结论:在 LDL-C 值范围内,HDL-C 与女性冠心病事件的发生呈一致的负相关。在总致动脉粥样硬化颗粒负担(载脂蛋白 B100 水平<0.90 g/L)较低的女性中,发生的事件较少,且未见相关性。
主要资金来源:默克公司和美国国立卫生研究院的国家心脏、肺和血液研究所以及国家癌症研究所。
Lipids Health Dis. 2025-5-24
BMC Complement Altern Med. 2019-9-5
JAMA. 2009-11-11
Circulation. 2005-11-29
J Am Coll Cardiol. 2005-11-1